CHOICE KERGUELEN 1: Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands: Inclusion of Volunteers Before Departure to the Kerguelen Islands

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-25

Study Completion Date

2025-09-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Living for long periods in extreme environments-like Antarctic research stations or space missions-can have a significant impact on human health, especially on the immune system. Scientists have observed that people in such isolated conditions often experience more infections and a reactivation of viruses that usually stay dormant in the body, such as Herpes viruses. These changes affect both parts of the immune system: the rapid-response "innate" system and the slower, more specific "adaptive" system.

These immune disruptions may be caused by multiple stressors: ongoing psychological stress, disturbed sleep and light cycles (circadian rhythm disruption), and the challenges of living in confined, isolated, and extreme environments. While space missions and Antarctic overwintering programs have provided some insight into these issues, scientists still lack a detailed understanding of how the immune system adapts-or fails to adapt-over time in such conditions.

To help fill this gap, the CHOICE Kerguelen 1 study will recrut a group of healthy young adults who will spend one year (from November 2025 to November 2026) in Port-aux-Français, a remote French research station on the Kerguelen Islands in the sub-Antarctic. These volunteers are participating in a civic service program and will be living in a highly isolated environment for the duration of their mission. The CHOICE Kerguelen 1 study is conducted in collaboration with the French Polar Institute (IPEV).The goal of the study is to collect and store a broad range of biological samples-including blood, saliva, stool, urine, and hair-from these volunteers before they leave for the island, to have baseline medical state and baseline biological samples. These samples will integrate in to healthy volunteer biobank of CHU Angers, a type of biological archive that provided control samples for CHOICE Kerguelen 2 - a clinical study relating to follow-up of volunteers during civic service on the Kerguelen Islands

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients

NCT00078663

Critical Illness

COMPLETED PHASE3

Risk of Bacterial Exposure to the Anesthesiologist's Face During Intubation and Extubation

NCT04673006

Anesthesiologists Who Perform Endotracheal Intubation and Extubation

COMPLETED

Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection

NCT04849585

Covid19

UNKNOWN

Infectious Diseases in Aged Population

NCT04825132

Respiratory Infections in Old Age Bacteremia

COMPLETED NA

Potential Risk for Bacterial Contamination in Ventilator Systems

NCT03359148

Contaminated Medical or Biological Substances Environmental-Pollution-Related Condition

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Health in Extreme Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HD (healthy donors)

blood ponction

Intervention Type OTHER

blood ponction

urines collection

Intervention Type OTHER

urines collection

hair collection

Intervention Type OTHER

hair collection

saliva collection

Intervention Type OTHER

saliva collection

stools collection

Intervention Type OTHER

stools collection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood ponction

Intervention Type OTHER

urines collection

Intervention Type OTHER

hair collection

Intervention Type OTHER

saliva collection

Intervention Type OTHER

stools collection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy people aged \> 18 years
* Participant affiliated with or benefiting from a social security system
* Participant has signed informed consent
* Participant staying as an overwintering member at Kerguelen from November 2025 to November 2026

Exclusion Criteria

* age \< 18 years
* Pregnant, breastfeeding, or postpartum woman
* immunocompromised people (primary immunodeficiency, HIV infection or immunosupressive treatment)
* Person refusing to participate in the study
* Person with a history of autoimmune disease - -Person deprived of liberty by judicial or administrative decision
* Person undergoing involuntary psychiatric treatment
* Person subject to a legal protection measure

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes